Stool Capsules Raised Peanut Tolerance in Six of Fifteen Adults in a First-of-Its-Kind Trial
Source: Medical Daily· Dorothy Brooks· August 7, 2026
SynaBot summary
A pilot study demonstrated that fecal microbiota transplantation, delivered via capsules, significantly increased peanut tolerance in a portion of adults with severe allergies. The positive effects were observed to persist for at least four months post-treatment.
Key takeaways
- Fecal capsules improved peanut tolerance in some adults.
- Tolerance effects lasted for four months.
- This is an early-stage research finding.
- Not yet a clinically approved treatment.
Why it matters
This research signals a potential new avenue for managing severe food allergies, moving beyond avoidance. For professionals relying on AI for health insights or managing dietary needs, it highlights emerging biotech that could eventually impact wellness and productivity.
This story was reported by Medical Daily. Read the full original article:
Read on Medical Daily 
